Recombinant Human RB1 Protein，Strep

RB1, or retinoblastoma protein, is a crucial tumor suppressor that plays a vital role in regulating the cell cycle and maintaining genomic stability. Mutations or dysfunction of the RB1 gene are implicated in various cancers, particularly retinoblastoma, a rare pediatric eye tumor. The study of RB1 recombinantly expressed proteins has gained significant attention due to its potential applications in cancer therapy and gene therapy. Recombinant RB1 proteins can be used to elucidate the molecular mechanisms underlying its tumor-suppressive functions and interactions with other cellular proteins, including E2F transcription factors and cyclins. This research also assists in exploring the biological effects of RB1 in normal and cancerous cells, offering insights into how restoring RB1 function might inhibit tumor growth. Additionally, expressing RB1 in a recombinant system allows for the production of large quantities of the protein, facilitating structural and functional studies necessary for drug development. This has led to an increased interest in developing RB1-based therapeutic strategies, such as gene therapy approaches that aim to restore normal RB1 function in tumors where it is lost or mutated. Overall, the understanding of RB1 through recombinant protein studies is pivotal for advancing cancer treatment modalities and improving patient outcomes.